Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2026-07-29

FDA Approved: TAMSULOSIN HYDROCHLORIDE — Supplemental Application (EXELAN PHARMACEUTICALS, INC.)

View source ↗

Summary

FDA supplemental application for tamsulosin hydrochloride submitted by Exelan Pharmaceuticals; indicates a label change request or updates to the approved produ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tamsulosin hydrochloride (tamsulosin hydrochloride)

Snippet

SUPPL AP for TAMSULOSIN HYDROCHLORIDE (TAMSULOSIN HYDROCHLORIDE)